Main Theme

The Lancet / JACC 1st Asia Pacific Cardiovascular Summit will offer a good opportunity for physicians specialising in the diagnosis, treatment, and management of cardiovascular disease to come together in an accessible location under the auspices of The Lancet and JACC. We hope a mix of local and international speakers will facilitate an authoritative discussion of the challenges and offer an opportunity to develop a consensus and way forward on the issues in this field.

The scientific committee is preparing an exciting and varied programme, which will feature the following topics.

Programme and Speakers at a Glance

Atrial Fibrillation

• BREAKTHROUGHS: Antithrombotics in atrial fibrillation
• CONTROVERSIES: Cardioversion versus rate control

Prevention

• BREAKTHROUGHS: Plaque assessment, vulnerable plaques
• CONTROVERSIES: Prescribing statins earlier/more intense statin therapy

Infection and Heart Disease

• BREAKTHROUGHS: Aetiology of hepatitis C virus in the Asia-Pacific region
• CONTROVERSIES: Cardiac fibrosis: genetic versus infectious aetiology

Percutaneous Coronary Intervention

• BREAKTHROUGHS: Unprotected left main intervention
• CONTROVERSIES: PCI versus optimum medical therapy / JACC award

Valvular Heart Disease

• BREAKTHROUGHS: Percutaneous valve replacement
• CONTROVERSIES: Mitral valve repair is appropriate in asymptomatic patients

Imaging

• BREAKTHROUGHS: To be confirmed
• CONTROVERSIES: Computed tomographic angiography (CTA)

Plenary: Advances in Acute Coronary Syndromes